| 1 |
O'Malley PA. So Where Is a Vaccine for Respiratory Syncytial Virus? Clin Nurse Spec 2023;37:58-60. [PMID: 36799700 DOI: 10.1097/NUR.0000000000000735] [Reference Citation Analysis]
|
| 2 |
Leroux-Roels I, Bruhwyler J, Stergiou L, Sumeray M, Joye J, Maes C, Lambert PH, Leroux-Roels G. Double-Blind, Placebo-Controlled, Dose-Escalating Study Evaluating the Safety and Immunogenicity of an Epitope-Specific Chemically Defined Nanoparticle RSV Vaccine. Vaccines (Basel) 2023;11. [PMID: 36851245 DOI: 10.3390/vaccines11020367] [Reference Citation Analysis]
|
| 3 |
Morens DM, Taubenberger JK, Fauci AS. Rethinking next-generation vaccines for coronaviruses, influenzaviruses, and other respiratory viruses. Cell Host Microbe 2023;31:146-57. [PMID: 36634620 DOI: 10.1016/j.chom.2022.11.016] [Reference Citation Analysis]
|
| 4 |
Bergeron HC, Kauvar LM, Tripp RA. Anti-G protein antibodies targeting the RSV G protein CX3C chemokine region improve the interferon response. Ther Adv Infect Dis 2023;10:20499361231161157. [PMID: 36938145 DOI: 10.1177/20499361231161157] [Reference Citation Analysis]
|
| 5 |
Riepl A, Straßmayr L, Voitl P, Ehlmaier P, Voitl JJM, Langer K, Kuzio U, Mühl-Riegler A, Mühl B, Diesner-Treiber SC. The surge of RSV and other respiratory viruses among children during the second COVID-19 pandemic winter season. Front Pediatr 2023;11:1112150. [PMID: 36816380 DOI: 10.3389/fped.2023.1112150] [Reference Citation Analysis]
|
| 6 |
Alkharsah KR. The Scope of Respiratory Syncytial Virus Infection in a Tertiary Hospital in the Eastern Province of Saudi Arabia and the Change in Seasonal Pattern during and after the COVID-19 Pandemic. Medicina (Kaunas) 2022;58. [PMID: 36363580 DOI: 10.3390/medicina58111623] [Reference Citation Analysis]
|
| 7 |
Wang Y, Zheng J, Wang X, Yang P, Zhao D. Alveolar macrophages and airway hyperresponsiveness associated with respiratory syncytial virus infection. Front Immunol 2022;13:1012048. [DOI: 10.3389/fimmu.2022.1012048] [Reference Citation Analysis]
|
| 8 |
Abu-Hanna J, Patel JA, Anastasakis E, Cohen R, Clapp LH, Loizidou M, Eddama MMR. Therapeutic potential of inhibiting histone 3 lysine 27 demethylases: a review of the literature. Clin Epigenetics 2022;14:98. [PMID: 35915507 DOI: 10.1186/s13148-022-01305-8] [Reference Citation Analysis]
|
| 9 |
Nakagome K, Nagata M. Innate Immune Responses by Respiratory Viruses, Including Rhinovirus, During Asthma Exacerbation. Front Immunol 2022;13:865973. [DOI: 10.3389/fimmu.2022.865973] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
|
| 10 |
Fang L, Roth M. Sensing of viral lung infections by cGAS-STING. Explor Immunol 2022. [DOI: 10.37349/ei.2022.00052] [Reference Citation Analysis]
|
| 11 |
Latorre V, Geller R. Identification of Cytoplasmic Chaperone Networks Relevant for Respiratory Syncytial Virus Replication. Front Microbiol 2022;13:880394. [PMID: 35615506 DOI: 10.3389/fmicb.2022.880394] [Reference Citation Analysis]
|
| 12 |
Zou P, Li G, Ge X, Wang J, Wang X, Li Y, Liu Y, Zhang J, Gui J, Wang Y. Lymphocyte subset changes in neonates with respiratory syncytial virus pneumonia. J Infect 2022:S0163-4453(22)00314-0. [PMID: 35623452 DOI: 10.1016/j.jinf.2022.05.025] [Reference Citation Analysis]
|
| 13 |
Murray J, Bergeron HC, Jones LP, Reener ZB, Martin DE, Sancilio FD, Tripp RA. Probenecid Inhibits Respiratory Syncytial Virus (RSV) Replication. Viruses 2022;14:912. [DOI: 10.3390/v14050912] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
|
| 14 |
Tripp RA, Martin DE. Repurposing Probenecid to Inhibit SARS-CoV-2, Influenza Virus, and Respiratory Syncytial Virus (RSV) Replication. Viruses 2022;14:612. [DOI: 10.3390/v14030612] [Reference Citation Analysis]
|
| 15 |
Latorre V, Geller R. Identification of cytoplasmic chaperone networks relevant for respiratory syncytial virus replication.. [DOI: 10.1101/2022.02.23.481726] [Reference Citation Analysis]
|
| 16 |
Pacheco GA, Gálvez NMS, Andrade CA, Vázquez Y, Rodríguez-guilarte L, González PA, Bueno SM, Kalergis AM. A recombinant BCG-based vaccine against the human respiratory syncytial virus induces a balanced cellular immune response against viral and mycobacterial antigens.. [DOI: 10.1101/2022.02.07.22270648] [Reference Citation Analysis]
|
| 17 |
Manti S, Piedimonte G. An overview on the RSV-mediated mechanisms in the onset of non-allergic asthma. Front Pediatr 2022;10:998296. [PMID: 36204661 DOI: 10.3389/fped.2022.998296] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
|
